We proactively think about and analyse the key issues that PHI fund leaders don't have time to.

We exist to help PHI leaders foster clinical and business innovation.


Our Services Include

Visual Commercial Perspectives

Entertaining and interactive deep data explorations parsing the challenges confronting PHI and appraising the the options vailable to PHI executives associated with resolving those problems for the betterment of their Fund and their fund's policyholders. Click here to see the releases schedule.

Customised Reports

Adapted from our established content library but crafted to meet the specific needs and situation of your fund. While the topics and data sets are in sync with our existing library, we fine-tune the data parameters to capture your Fund’s unique standpoint and we agree an appropriate narrative.

PHI Benchmarking Services

Commercial bio-markers and bird’s eye fund health checks. Use these services to identify and seize opportunities for performance augmentation.

Commercial Modelling Templates

  • Benefit outlay reduction programs.
  • Policholder growth investment pathways.
  • Lifetime member valuation models.

Supply & demand imbalance heat-maps.

Our heatmaps visualise provider distribution relative to community demand. They color-codes area according to relative supply and demand balance so you can quickly ascertain relative access levels for you policyholders.

PHI Consulting Services Including

  • Benefit outlay reduction audits.
  • Optimal member growth pathways.
  • Diversification outside of PHI strategy.
  • Capital and investment asset advisory.

The commercial panel develops all publications, data tools and models prepared by PHInsights

Dan Hilvert

Analytical Principal

Dan established PHInsigts with a desire to accelerate innovation in PHI. Dan has been a long-suffering believer in the potential for PHI to contribute much more to our healthcare system and believes the time is ripe for such innovation to occur. Dan has run a healthcare focussed corporate advisory firm over the past decade and in the decade prior, Dan ran Corporate Development for one of Australia’s leading health funds.

Sam Holt

Innovation Principal

Sam has established a series of healthcare ventures on behalf of top tier organisations including the Murdoch Children’s Research Institute, the Victorian Clinical Genetics Society and Medibank. Sam is also a passionate believer in the potential for PHI to deliver much more to Australian healthcare users.

Justin Begg

IT Systems Principal

Justin formerly an Associate Director in Healthcare and Health Payers at Accenture. Prior to that Justin was a GM in the DXC Technology Healthcare business, a leading global provider of Hospital, Pharmacy and other Healthcare and enterprise-wide Payer solutions (know Dedalus). Justin has also acted as strategic and technology adviser to two of Australia's leading health funds.

Matthew Moore

Operational Principal

Matthew has held CEO roles of two medium sized mutual PHI funds. He is an operational systems expert and also a fervent believer in the potential for PHI to deliver much more to Australian healthcare users.


We are on a mission to help funds make PHI considerably more affordable for younger and working age policyholders

Why working age policyholders? Because our community rated system relies on that group turning up. In the past decade, 10.3% of them have either left us or matured into the transitional age group. Right now, with soaring interest rates, we risk seeing that cohort leave us. Hence, cost reducing innovation isn’t just an option, it's an imperative – for the sake of PHI sustainability.


The Clinical Panel reviews benefit outlay reduction initiatives to gauge (a) clinical efficacy and (b) clinical implementation feasibility and (c) economic effectiveness

Clinical Panel recruitment underway, contact us for further information.